These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Treatment of Guillain-barre syndrome: immunoglobulins or plasmapheresis?]. Martínez Yélamos A; Huerta Villanueva M; Olivé Plana M; Montero Homs J; Serra Catafau J; Martínez-Matos JA Neurologia; 1998 Apr; 13(4):166-9. PubMed ID: 9608755 [TBL] [Abstract][Full Text] [Related]
4. Severe Guillain-Barré syndrome associated with Campylobacter jejuni infection with failure to respond to plasmapheresis and immunoglobulin. Allen A; Antony SJ J Am Board Fam Pract; 1999; 12(3):249-52. PubMed ID: 10395423 [No Abstract] [Full Text] [Related]
6. Intravenous immunoglobulin treatment in children with Guillain-Barre syndrome. Gürses N; Uysal S; Cetinkaya F; Işlek I; Kalayci AG Scand J Infect Dis; 1995; 27(3):241-3. PubMed ID: 8539548 [TBL] [Abstract][Full Text] [Related]
7. Guillain-Barré syndrome in childhood: natural course and efficacy of plasmapheresis. Jansen PW; Perkin RM; Ashwal S Pediatr Neurol; 1993; 9(1):16-20. PubMed ID: 8452594 [TBL] [Abstract][Full Text] [Related]
8. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome. Baskin E; Turkay S; Icagasioglu D; Tanzer F; Cevit O Turk J Pediatr; 1996; 38(1):119-23. PubMed ID: 8819632 [TBL] [Abstract][Full Text] [Related]
9. 'Immunoglobulin therapy in Guillain-Barré syndrome in children'. Ganesan V; Kirkham FJ Dev Med Child Neurol; 1996 Apr; 38(4):371-2. PubMed ID: 8641543 [No Abstract] [Full Text] [Related]
10. Natural history and treatment effects in Guillain-Barré syndrome: a multicentre study. Korinthenberg R; Mönting JS Arch Dis Child; 1996 Apr; 74(4):281-7. PubMed ID: 8669925 [TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin in two children with Guillain-Barré syndrome. Notarangelo LD; Duse M; Tiberti S; Guarneri B; Brunori A; Negrini A; Ugazio AG Eur J Pediatr; 1993 Apr; 152(4):372-4. PubMed ID: 8482293 [TBL] [Abstract][Full Text] [Related]
12. [Guillain-Barre syndrome in children in 2009-2014 years]. Stasiak K; Wesołowska E; Kroczka S Przegl Lek; 2016; 73(3):167-9. PubMed ID: 27349047 [TBL] [Abstract][Full Text] [Related]
13. [Guillain-Barré disease: a current treatment method using immunoglobulins]. Kleyweg RP; van der Meché FG Ned Tijdschr Geneeskd; 1992 Oct; 136(40):1956-60. PubMed ID: 1328903 [No Abstract] [Full Text] [Related]
14. [Use of intravenous immunoglobulins in Guillain-Barré syndrome]. Ceccarelli M; Assanta N; Chiaravalloti G; Rocopou C; Caiulo VA Minerva Pediatr; 1992 May; 44(5):237-40. PubMed ID: 1620076 [TBL] [Abstract][Full Text] [Related]
15. The role of plasmapheresis in childhood Guillain-Barré syndrome. Epstein MA; Sladky JT Ann Neurol; 1990 Jul; 28(1):65-9. PubMed ID: 2375635 [TBL] [Abstract][Full Text] [Related]
16. [Value of intravenous immunoglobulins. A case of Guillain-Barré syndrome]. Hidou M; Olivier J; Vivant JF Rev Neurol (Paris); 1992; 148(11):706-8. PubMed ID: 1303562 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis C associated with Guillain-Barré syndrome. Lacaille F; Zylberberg H; Hagège H; Roualdès B; Meyrignac C; Chousterman M; Girot R Liver; 1998 Feb; 18(1):49-51. PubMed ID: 9548267 [TBL] [Abstract][Full Text] [Related]
18. Severe Guillain-Barré syndrome during childhood responding to intravenous gammaglobulin. Heaton PA N Z Med J; 1992 Nov; 105(946):477-8. PubMed ID: 1436876 [No Abstract] [Full Text] [Related]
19. Single-dose intravenous immune globulin for treatment of Guillain-Barré syndrome. McGhee B; Jarjour IT Am J Hosp Pharm; 1994 Jan; 51(1):97-9. PubMed ID: 8135270 [No Abstract] [Full Text] [Related]